{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:08:45Z","timestamp":1793664525167,"version":"4.5.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,28]],"date-time":"2012-05-28T00:00:00Z","timestamp":1338163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,5,28]],"date-time":"2012-05-28T00:00:00Z","timestamp":1338163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                        <jats:title>Introduction\n<\/jats:title>\n                        <jats:p>The pathology of ankylosing spondylitis (AS) suggests that certain cytokines and matrix metalloproteinases (MMPs) might provide useful markers of disease activity. Serum levels of some cytokines and MMPs have been found to be elevated in active disease, but there is a general lack of information about biomarker profiles in AS and how these are related to disease activity and function. The purpose of this study was to investigate whether clinical measures of disease activity and function in AS are associated with particular profiles of circulating cytokines and MMPs.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods\n<\/jats:title>\n                        <jats:p>Measurement of 30 cytokines, five MMPs and four tissue inhibitors of metalloproteinases was carried out using Luminex<jats:sup>\u00ae<\/jats:sup> technology on a well-characterised population of AS patients (<jats:italic>n<\/jats:italic> = 157). The relationship between biomarker levels and measures of disease activity (Bath ankylosing spondylitis disease activity index (BASDAI)), function (Bath ankylosing spondylitis functional index) and global health (Bath ankylosing spondylitis global health) was investigated. Principal component analysis was used to reduce the large number of biomarkers to a smaller set of independent components, which were investigated for their association with clinical measures. Further analyses were carried out using hierarchical clustering, multiple regression or multivariate logistic regression.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results\n<\/jats:title>\n                        <jats:p>Principal component analysis identified eight clusters consisting of various combinations of cytokines and MMPs. The strongest association with the BASDAI was found with a component consisting of MMP-8, MMP-9, hepatocyte growth factor and CXCL8, and was independent of C-reactive protein levels. This component was also associated with current smoking. Hierarchical clustering revealed two distinct patient clusters that could be separated on the basis of MMP levels. The high MMP cluster was associated with increased C-reactive protein, the BASDAI and the Bath ankylosing spondylitis functional index.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions\n<\/jats:title>\n                        <jats:p>A profile consisting of high levels of MMP-8, MMP-9, hepatocyte growth factor and CXCL8 is associated with increased disease activity in AS. High MMP levels are also associated with smoking and worse function in AS.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3857","type":"journal-article","created":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T08:30:35Z","timestamp":1338539435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis"],"prefix":"10.1186","volume":"14","author":[{"given":"Derek L","family":"Mattey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Packham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola B","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Creamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hailwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon J","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok K","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,28]]},"reference":[{"key":"3604_CR1","first-page":"15.1","volume-title":"Rheumatology","author":"JT Gran","year":"1998","unstructured":"Gran JT, Husby G: Ankylosing spondylitis: prevalence and demography. Rheumatology. Edited by: Klippel JH, Dieppe PA. 1998, London: Mosby, 15.1-15.6. 2","edition":"2"},{"key":"3604_CR2","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A","volume":"44","author":"J Hamersma","year":"2001","unstructured":"Hamersma J, Cardon LR, Bradbury L, Brophy S, van-der Horst-Bruinsma I, Calin A, Brown MA: Is disease severity in ankylosing spondylitis genetically determined?. Arthritis Rheum. 2001, 44: 1396-1400. 10.1002\/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A.","journal-title":"Arthritis Rheum"},{"key":"3604_CR3","first-page":"966","volume":"26","author":"J Ruof","year":"1999","unstructured":"Ruof J, Stucki G: Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol. 1999, 26: 966-970.","journal-title":"J Rheumatol"},{"key":"3604_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/rheumatology\/33.10.927","volume":"33","author":"J Gratac\u00f3s","year":"1994","unstructured":"Gratac\u00f3s J, Collado A, Fillela X, Sanmarti R, Canete J, Llena J, Molina R, Ballesta A, Mu\u00f1oz-G\u00f3mez J: Serum cytokines (IL-6, TNF-alpha, IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol. 1994, 33: 927-931. 10.1093\/rheumatology\/33.10.927.","journal-title":"Br J Rheumatol"},{"key":"3604_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/rheumatology\/36.3.400","volume":"36","author":"P Claudepierre","year":"1997","unstructured":"Claudepierre P, Rymer J-C, Authier F-J, Allanore Y, Larget-Piet B, Gherardi R, Chevalier X: A relationship between TGF-\u03b21 or IL-6 plasma levels and clinical features of spondyloarthropathies. Br J Rheumatol. 1997, 36: 400-401. 10.1093\/rheumatology\/36.3.400.","journal-title":"Br J Rheumatol"},{"key":"3604_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10067-006-0283-5","volume":"26","author":"A Bal","year":"2007","unstructured":"Bal A, Unlu E, Bahar G, Aydog E, Eksioglu E, Yorgancioglu R: Comparison of serum IL-1 beta, IL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol. 2007, 26: 211-215.","journal-title":"Clin Rheumatol"},{"key":"3604_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/rheumatology\/keh426","volume":"44","author":"HS Howe","year":"2005","unstructured":"Howe HS, Cheung PL, Kong KO, Badsha H, Thong BY, Leong KP, Koh ET, Lian TY, Cheng YK, Lam S, Teo D, Lau TC, Leung BP: Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis. Rheumatology. 2005, 44: 51-54. 10.1093\/rheumatology\/keh426.","journal-title":"Rheumatology"},{"key":"3604_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1046\/j.1365-2249.2003.02101.x","volume":"132","author":"M Drouart","year":"2003","unstructured":"Drouart M, Saas P, Billot M, Cedoz JP, Tiberghien P, Wendling D, Toussirot E: High serum vascular endothelial growth factor correlates with disease activity of spondyloarthropathies. Clin Exp Immunol. 2003, 132: 158-162. 10.1046\/j.1365-2249.2003.02101.x.","journal-title":"Clin Exp Immunol"},{"key":"3604_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/art.20696","volume":"51","author":"C Yang","year":"2004","unstructured":"Yang C, Gu J, Rihl M, Baeten D, Huang F, Zhao M, Zhang H, Maksymowych WP, De Keyser F, Veys EM, Yu DTY: Serum levels of matrix metalloproteinase 3 and macrophage colony stimulating factor 1 correlate with disease activity in ankylosing spondylitis. Arthritis Rheum (Arthritis Care Res). 2004, 51: 691-699. 10.1002\/art.20696.","journal-title":"Arthritis Rheum (Arthritis Care Res)"},{"key":"3604_CR10","first-page":"1753","volume":"34","author":"JH Woo","year":"2007","unstructured":"Woo JH, Lee HJ, Sung IH, Kim TH: Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept. J Rheumatol. 2007, 34: 1753-1759.","journal-title":"J Rheumatol"},{"key":"3604_CR11","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1186\/ar2537","volume":"10","author":"H Appel","year":"2008","unstructured":"Appel H, Janssen L, Listing J, Heydrich R, Rudwaleit M, Sieper J: Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment. Arthritis Res Ther. 2008, 10: R125-10.1186\/ar2537.","journal-title":"Arthritis Res Ther"},{"key":"3604_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/ard.2007.071605","volume":"67","author":"S Visvanathan","year":"2008","unstructured":"Visvanathan S, Wagner C, Marini JC, Baker D, Gathany T, Han J, van der Heijde D, Braun J: Inflammatory biomarkers, disease activity and spinal measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis. 2008, 67: 511-517.","journal-title":"Ann Rheum Dis"},{"key":"3604_CR13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s10067-010-1528-x","volume":"29","author":"SJ Pedersen","year":"2010","unstructured":"Pedersen SJ, Hetland ML, Sorensen IJ, Ostergaard M, Nielsen H, Johansen JS: Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNF\u03b1 inhibitors. Clin Rheumatol. 2010, 29: 1301-1309. 10.1007\/s10067-010-1528-x.","journal-title":"Clin Rheumatol"},{"key":"3604_CR14","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/ard.2010.138883","volume":"70","author":"SJ Pedersen","year":"2011","unstructured":"Pedersen SJ, S\u00f8rensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Smedegaard L, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Jurik AG, M\u00f8ller J, Hasselquist M, Mikkelsen D, Skj\u00f8dt T, Lambert R, Hansen A, \u00d8stergaard M: ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with with TNF\u03b1 inhibitors. Ann Rheum Dis. 2011, 70: 1375-1381. 10.1136\/ard.2010.138883.","journal-title":"Ann Rheum Dis"},{"key":"3604_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/ard.2003.011023","volume":"62","author":"C Keller","year":"2003","unstructured":"Keller C, Webb A, Davis J: Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review. Ann Rheum Dis. 2003, 62: 128-132.","journal-title":"Ann Rheum Dis"},{"key":"3604_CR16","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1002\/art.20477","volume":"50","author":"B Vandooren","year":"2004","unstructured":"Vandooren B, Kruithof E, Yu DTY, Rihl M, Gu J, De Rycke L, Van den Bosch F, Veys EM, De Keyser F, Baeten D: Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regualtion by tumor necrosis factor \u03b1 blockade in spondyloarthropathy. Arthritis Rheum. 2004, 50: 2942-2953. 10.1002\/art.20477.","journal-title":"Arthritis Rheum"},{"key":"3604_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","volume":"45","author":"C-H Chen","year":"2006","unstructured":"Chen C-H, Lin K-C, Yu DTY, Yang C, Huang F, Chen H-A, Liang T-H, Liao H-T, Tsai C-Y, Wei JCC, Chou C-T: Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology. 2006, 45: 414-420. 10.1093\/rheumatology\/kei208.","journal-title":"Rheumatology"},{"key":"3604_CR18","first-page":"1911","volume":"32","author":"WP Maksymowych","year":"2005","unstructured":"Maksymowych WP, Poole RA, Hiebert L, Webb A, Ionescu M, Lobanok T, King L, Davis JC: Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis. J Rheumatol. 2005, 32: 1911-1917.","journal-title":"J Rheumatol"},{"key":"3604_CR19","first-page":"2030","volume":"35","author":"WP Maksymowych","year":"2008","unstructured":"Maksymowych WP, Rahman P, Shojania K, Olsynski WP, Thomson GT, Ballal S, Wong RL, Inman RD, M03-606 Study Group, Bell MJ, Keystone E, Martin WO, Beaulieu A, Choquette D, Chardonnet L, He Y, Nissen M, Lush L: Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis. J Rheumatol. 2008, 35: 2030-2037.","journal-title":"J Rheumatol"},{"key":"3604_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jbspin.2008.01.026","volume":"75","author":"D Wendling","year":"2008","unstructured":"Wendling D, Cedoz J-P, Racador E: Serum levels of MMP-3 and cathepsin K in patients with anklosing spondyltis: effect of TNF\u03b1 antagonist therapy. Joint Bone Spine. 2008, 75: 559-562. 10.1016\/j.jbspin.2008.01.026.","journal-title":"Joint Bone Spine"},{"key":"3604_CR21","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s10067-008-0941-x","volume":"27","author":"C Romero-Sanchez","year":"2008","unstructured":"Romero-Sanchez C, Robinson WH, Tomooka BH, Londono J, Valle-Onate R, Huang F, Deng X, Zhang L, Yang C, Yu DT: Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis. Clin Rheumatol. 2008, 27: 1429-1435. 10.1007\/s10067-008-0941-x.","journal-title":"Clin Rheumatol"},{"key":"3604_CR22","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3899\/jrheum.101128","volume":"38","author":"S Arends","year":"2011","unstructured":"Arends S, van der Veer E, Groen H, Houtman PM, Jansen TL, Leijsma MK, Bijzet J, Limburg PC, Kallenberg CG, Spoorenberg A, Brouwer E: Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis. J Rheumatol. 2011, 38: 1644-1650. 10.3899\/jrheum.101128.","journal-title":"J Rheumatol"},{"key":"3604_CR23","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/art.22589","volume":"56","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych WP, Landewe R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole RA, Wang N, van der Heijde D: Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum. 2007, 56: 1846-1853. 10.1002\/art.22589.","journal-title":"Arthritis Rheum"},{"key":"3604_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Van der Linden","year":"1984","unstructured":"Van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984, 27: 361-368. 10.1002\/art.1780270401.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"3604_CR25","first-page":"128.Abstract.","volume":"70","author":"L Coates","year":"2011","unstructured":"Coates L, Bhalla A, Creamer P, Hailwood S, Mattey D, Packham J, Taylor G, BIAS Study Group: The effect of alendronate on ankylosing spondylitis; the results of the bisphosphonates in ankylosing spondylitis trial (BIAS). Ann Rheum Dis. 2011, 70 (Suppl 3): 128.Abstract.-","journal-title":"Ann Rheum Dis"},{"key":"3604_CR26","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.3899\/jrheum.110641","volume":"38","author":"DL Mattey","year":"2011","unstructured":"Mattey DL, Dawson SR, Healey EL, Packham JC: Relationship between smoking and patient reported measures of disease outcome in ankylosing spondylitis. J Rheumatol. 2011, 38: 2608-2615. 10.3899\/jrheum.110641.","journal-title":"J Rheumatol"},{"key":"3604_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2307\/2347164","volume":"27","author":"CE McHenry","year":"1978","unstructured":"McHenry CE: Computation of a best subset in multivariate analysis. Appl Stat. 1978, 27: 291-296. 10.2307\/2347164.","journal-title":"Appl Stat"},{"key":"3604_CR28","doi-asserted-by":"crossref","DOI":"10.1002\/9781119013563","volume-title":"Statistical Analysis with Missing Data","author":"RJA Little","year":"2002","unstructured":"Little RJA, Rubin DB: Statistical Analysis with Missing Data. 2002, Wiley-Interscience; New York, 2","edition":"2"},{"key":"3604_CR29","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.4049\/jimmunol.169.5.2643","volume":"169","author":"T Itoh","year":"2002","unstructured":"Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R: The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody induced arthritis. J Immunol. 2002, 169: 2643-2647.","journal-title":"J Immunol"},{"key":"3604_CR30","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/ar1849","volume":"8","author":"J Rodriguez-Lopez","year":"2006","unstructured":"Rodriguez-Lopez J, Perez-Pampin E, Gomez-Reino JJ, Gonzalez A: Regulatory polymorphisms in extracellular matrix protease genes and susceptibility to rheumatoid arthritis: a case-control study. Arthritis Res Ther. 2006, 8: R1-10.1186\/ar1849.","journal-title":"Arthritis Res Ther"},{"key":"3604_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1034\/j.1600-065X.2000.17706.x","volume":"177","author":"P Scapini","year":"2000","unstructured":"Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA: The neutrophil as a cellular source of chemokines. Immunol Rev. 2000, 177: 195-203. 10.1034\/j.1600-065X.2000.17706.x.","journal-title":"Immunol Rev"},{"key":"3604_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/01.TA.0000111752.60500.DA","volume":"56","author":"A Matsushima","year":"2004","unstructured":"Matsushima A, Ogura H, Koh T, Fujita K, Yoshiya K, Sumi Y, Hosotsubo H, Kuwagata Y, Tanaka H, Shimazu T, Sugimoto H: Hepatocyte growth factor in polymorphonuclear leukocytes is increased in patients with systemic inflammatory response syndrome. J Trauma. 2004, 56: 259-264. 10.1097\/01.TA.0000111752.60500.DA.","journal-title":"J Trauma"},{"key":"3604_CR33","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/01.ATV.0000209518.58252.17","volume":"26","author":"VW van Hinsbergh","year":"2006","unstructured":"van Hinsbergh VW, Engelse MA, Quax PH: Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol. 2006, 26: 716-728. 10.1161\/01.ATV.0000209518.58252.17.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3604_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1600-0463.2004.apm11207-0808.x","volume":"112","author":"MM Rosenkilde","year":"2004","unstructured":"Rosenkilde MM, Schwartz TW: The chemokine system - a major regulator of angiogenesis in health and disease. APMIS. 2004, 112: 481-495. 10.1111\/j.1600-0463.2004.apm11207-0808.x.","journal-title":"APMIS"},{"key":"3604_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.ATV.0000048701.86621.D0","volume":"23","author":"S Sengupta","year":"2003","unstructured":"Sengupta S, Gherardi E, Sellers LA, Wood JM, Sasisekharan R, Fan TP: Hepatocyte growth factor\/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2003, 23: 69-75. 10.1161\/01.ATV.0000048701.86621.D0.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3604_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cca.2006.12.006","volume":"379","author":"CL Aquilante","year":"2007","unstructured":"Aquilante CL, Beitelshees AL, Zineh I: Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease. Clin Chim Acta. 2007, 379: 48-52. 10.1016\/j.cca.2006.12.006.","journal-title":"Clin Chim Acta"},{"key":"3604_CR37","doi-asserted-by":"publisher","first-page":"e1774","DOI":"10.1371\/journal.pone.0001774","volume":"3","author":"P Garvin","year":"2008","unstructured":"Garvin P, Nilsson L, Carstensen J, Jonasson L, Kristenson M: Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle aged normal population. PloS One. 2008, 3: e1774-10.1371\/journal.pone.0001774. doi: 10.1371\/journal.pone.0001774","journal-title":"PloS One"},{"key":"3604_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0021-9150(98)00163-4","volume":"141","author":"AD Blann","year":"1998","unstructured":"Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN: The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis. 1998, 141: 133-139. 10.1016\/S0021-9150(98)00163-4.","journal-title":"Atherosclerosis"},{"key":"3604_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s005990070005","volume":"30","author":"A Gustaffson","year":"2000","unstructured":"Gustaffson A, Asman B, Bergstrom K: Cigarette smoking as an aggravating factor in inflammatory tissue-destructive diseases. Increase in tumor-necrosis factor-alpha priming of peripheral neutrophils measured as generation of oxygen radicals. Int J Clin Lab Res. 2000, 30: 187-190. 10.1007\/s005990070005.","journal-title":"Int J Clin Lab Res"},{"key":"3604_CR40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/03009749609080003","volume":"25","author":"HL Averns","year":"1996","unstructured":"Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT: Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol. 1996, 25: 138-142. 10.3109\/03009749609080003.","journal-title":"Scand J Rheumatol"},{"key":"3604_CR41","first-page":"1420","volume":"29","author":"MM Ward","year":"2002","unstructured":"Ward MM: Predictors of the progression of functional disability in patients with ankylosing spondylitis. J Rheumatol. 2002, 29: 1420-1425.","journal-title":"J Rheumatol"},{"key":"3604_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1445-5994.2007.01471.x","volume":"38","author":"MD Reed","year":"2008","unstructured":"Reed MD, Dharmage S, Boers A, Martin BJ, Buchanan RR, Schachna L: Ankylosing spondylitis: an Australian experience. Intern Med J. 2008, 38: 321-327. 10.1111\/j.1445-5994.2007.01471.x.","journal-title":"Intern Med J"},{"key":"3604_CR43","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/annrheumdis-2011-200180","volume":"71","author":"HY Chung","year":"2012","unstructured":"Chung HY, Machado P, van der Heijde D, D'Agostino MA, Dougados M: Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis. 2012, 71: 809-816. 10.1136\/annrheumdis-2011-200180.","journal-title":"Ann Rheum Dis"},{"key":"3604_CR44","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Haibel H, Listing J, Marker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M: Baseline radiographic damage, elevated acute phase reactants and cigarette smoking status predict radiographic progression in the spine in early axial spondyloarthritis. Arthritis Rheum. 2012, 64: 1388-1398. 10.1002\/art.33465.","journal-title":"Arthritis Rheum"},{"key":"3604_CR45","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/ard.60.8.750","volume":"60","author":"D Baeten","year":"2001","unstructured":"Baeten D, Van Damme N, Van den Bosch F, Kruithof E, De Vos M, Mielants H, Veys EM, De Keyser F: Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNF\u03b1. Ann Rheum Dis. 2001, 60: 750-755. 10.1136\/ard.60.8.750.","journal-title":"Ann Rheum Dis"},{"key":"3604_CR46","doi-asserted-by":"publisher","first-page":"R359","DOI":"10.1186\/ar1501","volume":"7","author":"D Baeten","year":"2005","unstructured":"Baeten D, Kruithof E, De Rycke L, Boots AM, Mielants H, Veys EM, de Keyser F: Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy. Arthritis Res Ther. 2005, 7: R359-R369. 10.1186\/ar1501.","journal-title":"Arthritis Res Ther"},{"key":"3604_CR47","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McConagle","year":"2006","unstructured":"McConagle D, McDermott MF: A proposed classification of the immunological diseases. PloS Med. 2006, 3: e297-10.1371\/journal.pmed.0030297.","journal-title":"PloS Med"},{"key":"3604_CR48","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1186\/ar3370","volume":"13","author":"H Appel","year":"2011","unstructured":"Appel H, Maier R, Wu P, Scheer R, Hempfing A, Kayser R, Thiel A, Radbruch A, Loddenkemper C, Sieper J: Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther. 2011, 13: R95-10.1186\/ar3370.","journal-title":"Arthritis Res Ther"},{"key":"3604_CR49","first-page":"47","volume":"16","author":"H Repo","year":"1984","unstructured":"Repo H, Leirisalo-Repo M, Koivuranta-Vaara P: Exaggerated inflammatory responsiveness plays a part in the pathogenesis of HLA-B27 linked disease - hypothesis. Ann Clin Res. 1984, 16: 47-50.","journal-title":"Ann Clin Res"},{"key":"3604_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/ard.48.1.35","volume":"48","author":"CT Pease","year":"1989","unstructured":"Pease CT, Fennell M, Brewerton DA: Polymorphonuclear leucocyte motility in men with ankylosing spondylitis. Ann Rheum Dis. 1989, 48: 35-41. 10.1136\/ard.48.1.35.","journal-title":"Ann Rheum Dis"},{"key":"3604_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF00332560","volume":"11","author":"D Wendling","year":"1991","unstructured":"Wendling D, Didier JM, Vuitton DA: The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int. 1991, 11: 187-189. 10.1007\/BF00332560.","journal-title":"Rheumatol Int"},{"key":"3604_CR52","first-page":"623","volume":"13","author":"D Biasi","year":"1995","unstructured":"Biasi D, Carletto A, Caramaschi P, Bellavite P, Andrioli G, Caraffi M, Pacor ML, Bambara LM: Neutrophil functions, spondyloarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol. 1995, 13: 623-627.","journal-title":"Clin Exp Rheumatol"},{"key":"3604_CR53","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/ard.59.5.338","volume":"59","author":"K-J Ho","year":"2000","unstructured":"Ho K-J, Chen P-Q, Chang C-Y, Lu F-J: The oxidative metabolism of circulating phagocytes in ankylosing spondyltis: determination by whole blood chemiluminescence. Ann Rheum Dis. 2000, 59: 338-341. 10.1136\/ard.59.5.338.","journal-title":"Ann Rheum Dis"},{"key":"3604_CR54","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/rheumatology\/keh317","volume":"43","author":"C Yazici","year":"2004","unstructured":"Yazici C, Kose K, Calis M, Kuzuguden S, Kirnap M: Protein oxidation status in patients with ankylosing spondylitis. Rheumatology. 2004, 43: 1235-1239. 10.1093\/rheumatology\/keh317.","journal-title":"Rheumatology"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3857\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:32:59Z","timestamp":1728383579000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,28]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,6]]}},"alternative-id":["3604"],"URL":"https:\/\/doi.org\/10.1186\/ar3857","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,28]]},"assertion":[{"value":"2 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R127"}}